Cargando…
Polidocanol foam sclerotherapy in the treatment of hemorrhoidal disease in patients with bleeding disorders: a multicenter, prospective, cohort study
BACKGROUND: The management of hemorrhoidal disease (HD) in patients with bleeding disorders (BD) is challenging. Polidocanol foam sclerotherapy (PFS) is associated with a low rate of bleeding complications. The aim of this study was to compare the efficacy and safety of PFS in the treatment of HD in...
Autores principales: | Salgueiro, P., Rei, A., Garrido, M., Rosa, B., Oliveira, A. M., Pereira-Guedes, T., Morais, S., Castro-Poças, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879173/ https://www.ncbi.nlm.nih.gov/pubmed/35217937 http://dx.doi.org/10.1007/s10151-022-02600-5 |
Ejemplares similares
-
Sclerotherapy with 3% polidocanol foam for third- and fourth-degree hemorrhoids as “bridge treatment” during the COVID-19 pandemic in Italy
por: Lisi, Giorgio, et al.
Publicado: (2021) -
Sclerotherapy using polidocanol foam for a giant splenic cyst
por: Funakoshi, Hiraku, et al.
Publicado: (2020) -
Foam Polidocanol Sclerotherapy for Low-Flow Vascular Malformations of Tongue
por: Mukul, Sailesh Kumar, et al.
Publicado: (2019) -
Bilateral foam polidocanol sclerotherapy of great saphenous veins and their tributaries in synchronous procedure
por: Miranda, Luiz Antonio, et al.
Publicado: (2021) -
Sclerotherapy with 3% polidocanol foam: revolutionizing outpatient treatment in patients with haemorrhoidal disease
por: Gallo, Gaetano, et al.
Publicado: (2021)